RIZZO, FEDERICA
RIZZO, FEDERICA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Advances and challenges in modeling Charcot-Marie-Tooth type 2A using iPSC-derived models
2025 M. Rizzuti, E. Pagliari, M. D'Agostino, L. Ottoboni, V. Parente, G.P. Comi, S. Corti, F. Rizzo, E. Abati
Targeting STMN2 for neuroprotection and neuromuscular recovery in Spinal Muscular Atrophy: evidence from in vitro and in vivo SMA models
2025 E. Pagliari, M. Taiana, P. Manzini, L. Sali, L. Quetti, L. Bertolasi, S. Oldoni, V. Melzi, G. Comi, S. Corti, M. Nizzardo, F. Rizzo
Charcot-Marie-Tooth type 2A in vivo models: Current updates
2024 E. Abati, M. Rizzuti, A. Anastasia, G.P. Comi, S. Corti, F. Rizzo
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives
2024 C. Alberti, F. Rizzo, A. Anastasia, G. Comi, S. Corti, E. Abati
Investigating the prevalence of MFN2 mutations in amyotrophic lateral sclerosis: insights from an Italian cohort
2024 E. Abati, D. Gagliardi, A. Manini, R. Del Bo, D. Ronchi, M. Meneri, F. Beretta, A. Sarno, F. Rizzo, E. Monfrini, A. Di Fonzo, M.T. Pellecchia, A. Brusati, V. Silani, G.P. Comi, A. Ratti, F. Verde, N. Ticozzi, S. Corti
Stathmins and Motor Neuron Diseases: Pathophysiology and Therapeutic Targets
2022 D. Gagliardi, E. Pagliari, M. Meneri, V. Melzi, F. Rizzo, G.P. Comi, S.P. Corti, M.M. Taiana, M. Nizzardo
Clinical and genetic features of a cohort of patients with MFN2-related neuropathy
2022 E. Abati, A. Manini, D. Velardo, R. Del Bo, L. Napoli, F. Rizzo, M. Moggio, N. Bresolin, E. Bellone, M.T. Bassi, M.G. D'Angelo, G.P. Comi, S. Corti
Neural stem cell transplantation for neurodegenerative diseases
2020 R. De Gioia, F. Biella, G. Citterio, F. Rizzo, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti
Synaptotagmin 13 is neuroprotective across motor neuron diseases
2020 M. Nizzardo, M. Taiana, F. Rizzo, J. Aguila Benitez, J. Nijssen, I. Allodi, V. Melzi, N. Bresolin, G.P. Comi, E. Hedlund, S. Corti
Animal Models of CMT2A: State-of-art and Therapeutic Implications
2020 R. De Gioia, G. Citterio, E. Abati, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, F. Rizzo
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
2019 K. Barbullushi, E. Abati, F. Rizzo, N. Bresolin, G.P. Comi, S. Corti
Key role of SMN/SYNCRIP and RNA-Motif 7 in spinal muscular atrophy: RNA-Seq and motif analysis of human motor neurons
2019 F. Rizzo, M. Nizzardo, S. Vashisht, E. Molteni, V. Melzi, M. Taiana, S. Salani, P. Santonicola, E. Di Schiavi, M. Bucchia, A. Bordoni, I. Faravelli, N. Bresolin, G.P. Comi, U. Pozzoli, S. Corti
Downregulation of glutamic acid decarboxylase in Drosophila TDP- 43-null brains provokes paralysis by affecting the organization of the neuromuscular synapses
2018 G. Romano, N. Holodkov, R. Klima, F. Grilli, C. Guarnaccia, M. Nizzardo, F. Rizzo, R. Garcia, F. Feiguin
Genome-wide RNA-seq and proteomic analysis of motor neurons indicates selective cytoskeletal perturbation in Brown-Vialetto disease, partially rescued by riboflavin
2017 F. Rizzo, A. Ramirez, C. Compagnucci, S. Salani, V. Melzi, A. Bordoni, F. Fortunato, N. Bresolin, G.P. Comi, E. Bertini, M. Nizzardo, S. Corti
Peptide-conjugated Morpholino Oligomers for treatment of Spinal Muscular Atrophy
2016 A. Ramirez, M. Rizzuti, F. Rizzo, P. Rinchetti, M. Bucchia, N. Bresolin, G.P. Comi, S. Corti, M. Nizzardo
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype
2016 M. Nizzardo, C. Simone, F. Rizzo, G. Ulzi, A. Ramirez, M. Rizzuti, A. Bordoni, M. Bucchia, S. Gatti, N. Bresolin, G.P. Comi, S. Corti
Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neurons
2016 F. Rizzo, D. Ronchi, S. Salani, M. Nizzardo, F. Fortunato, A. Bordoni, G. Stuppia, R. Del Bo, D. Piga, R. Fato, N. Bresolin, G.P. Comi, S. Corti
Morpholino antisense oligomer against SOD1 for amyotrophic lateral sclerosis therapy
2015 C. Simone, M. Nizzardo, F. Rizzo, G. Ulzi, A. Ramirez, M. Bucchia, A. Bordoni, G. Comi, S. Corti
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives
2015 G. Stuppia, F. Rizzo, G. Riboldi, R. Del Bo, M. Nizzardo, C. Simone, G.P. Comi, N. Bresolin, S. Corti
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model
2015 M. Nizzardo, C. Simone, F. Rizzo, S. Salani, P. Rinchetti, R. Del Bo, S. Dametti, K. Foust, B. Kaspar, N. Bresolin, G. Comi, S. Corti